Tilray Brands (TLRY) Profit After Tax (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Profit After Tax (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -57.60% |
| Feb 28, 2026 | 19.38% |
| Nov 30, 2025 | -3,046.79% |
| Aug 31, 2025 | 100.10% |
| May 31, 2025 | -58.10% |
| Feb 28, 2025 | -747.74% |
| Nov 30, 2024 | -209.07% |
| Aug 31, 2024 | 3.95% |
| May 31, 2024 | 71.05% |
| Feb 29, 2024 | -167.64% |
| Nov 30, 2023 | 22.17% |
| Aug 31, 2023 | 63.02% |
| May 31, 2023 | 88.09% |
| Feb 28, 2023 | -1,051.15% |
| Nov 30, 2022 | 21.57% |
| Aug 31, 2022 | 73.51% |
| May 31, 2022 | -1,052.67% |
| Feb 28, 2022 | 222.39% |
| Nov 30, 2021 | 68.48% |
| Aug 31, 2021 | -388.16% |